JOURNAL OF DRUGS IN DERMATOLOGY

JOURNAL OF DRUGS IN DERMATOLOGY Journal

publication venue for

Skin Cancer Screening Practices Among Dermatologists: A Survey Study. 21:1235-1241. 2022
Evidence Threshold for a Precision Medicine Test that Predicts Optimal Response to a Biologic Agent in Patients With Psoriasis: A Consensus Panel. 21:628-634. 2022
Open-Label Cohort Study to Evaluate Efficacy and Safety of Application of Glycopyrronium Cloth, 2.4% for Palmar Hyperhidrosis. 21:488-494. 2022
Recapture Rate of Brodalumab in Patients With a Lapse in Treatment. 19:384-387. 2020
Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate and Severe Acne Vulgaris in Females: Effect of Age on Efficacy and Tolerability. 18:1218-1225. 2019
Efficacy of Dupilumab in Different Racial Subgroups of Adults With Moderate-to-Severe Atopic Dermatitis in Three Randomized, Placebo-Controlled Phase 3 Trials. 18:804-813. 2019
Systemic Therapies for Moderate-to-Severe Atopic Dermatitis: Expert Perspectives in Practice. 18:122-129. 2019
Use of Apremilast for Aphthous Ulcers in a Patient With Behcet's Syndrome. 17:1328-1329. 2018
Use of Apremilast for Aphthous Ulcers in a Patient With Behcet's Syndrome. 17:1328-1329. 2018
Understanding Patient Experience With Hyperhidrosis: A National Survey of 1,985 Patients. 17:392-396. 2018
Treatment of Inverse/Intertriginous Psoriasis: Updated Guidelines from the Medical Board of the National Psoriasis Foundation. 16:760-766. 2017
Treatment of Inverse/Intertriginous Psoriasis: Updated Guidelines from the Medical Board of the National Psoriasis Foundation. 16:760-766. 2017
Geographic Variations in Biologic Therapy and Disease Characteristics: A Pilot-Study in the Corrona Psoriasis Registry 2020
Severe Small-Vessel Vasculitis Temporally Associated With Administration of Ustekinumab. 2016

International Standard Serial Number (ISSN)

1545-9616